54 results
8-K
NOTV
Inotiv Inc
20 Apr 21
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021
5:16pm
standards, and expenses for rebranding and new website launch.
For Bolder BioPATH, Inc. and Histotox Labs, Inc (collectively, the “Targets”), the non-GAAP … in accordance with GAAP. Management, however, believes that the Company's Adjusted EBITDA and the non-GAAP information presented for the Targets, when
8-K
EX-99.1
NOTV
Inotiv Inc
11 Feb 22
Regulation FD Disclosure
4:47pm
the Company and certain of its recent acquisition targets that has not been previously disclosed. That information included historical revenues and Adjusted … EBITDA information for the Company and for the acquisition targets for the 12-month period ended September 30, 2021 (the “LTM Period”). The acquisition
8-K
EX-99.2
3tgib4 lg
21 Sep 21
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
9:53am
8-K
EX-99.5
ui55z
21 Sep 21
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
5:30pm
424B3
l7wunayvbgi97c
4 Jun 14
Prospectus supplement
12:00am